Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, Maeno T, Minato K, Tomono H, Ogawara D, Mukae H, Miura Y, Shiono A, Mouri A, Kagamu H, Kaira K.
Yamaguchi O, et al. Among authors: imai h.
Sci Rep. 2023 Nov 27;13(1):20848. doi: 10.1038/s41598-023-48210-5.
Sci Rep. 2023.
PMID: 38012343
Free PMC article.